We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

9 hedge funds and large institutions have $1.89M invested in ENDRA Life Sciences in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

13% more funds holding

Funds holding: 89 (+1)

2% more capital invested

Capital invested by funds: $1.86M → $1.89M (+$28K)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NDRA Hedge Fund Activity: Q1 2019 in Review

9 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2019, worth a combined $1.89M — up 1.5% from $1.86M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NDRA positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $73K. The largest seller was SeaCrest Wealth Management, cutting an estimated $146K.

  • 9 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2019, up from 8 in Q4 2018.
  • Funds reported $1.89M of ENDRA Life Sciences stock for Q1 2019, up 1.5% quarter-over-quarter.
  • 2 funds opened new ENDRA Life Sciences positions in Q1 2019 and 1 closed out, a net change of +1 holder.
  • The largest ENDRA Life Sciences buyer in Q1 2019 was Citadel Advisors, an estimated $73K added.
  • The largest ENDRA Life Sciences seller in Q1 2019 was SeaCrest Wealth Management, an estimated $146K sold.

Based on aggregated 13F filings for Q1 2019.